A new simple method for assessing sudomotor function: Relevance in type 2 diabetes;Une nouvelle méthode simple pour évaluer la function sudomotrice intérêt dans le diabète de type 2.

Diabetes and Metabolism

Volumn 36, Issue 6, 2010, Pages 450-454

  Mayaudon, H ^a   Miloche, P O ^b   Bauduceau, B ^a  

^a SERVICE D ENDOCRINOLOGIE   (France)

^b Deuxième régiment de dragons ^*  (France)

Author keywords

Autonomic nervous system; Electrochemical skin conductance; EZSCAN; Sudomotor function; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC PATIENT; DIAGNOSTIC ACCURACY; ELECTROCHEMICAL SKIN CONDUCTANCE; FEASIBILITY STUDY; FEMALE; FOOT; FOREHEAD; HAND; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SKIN CONDUCTANCE; SWEATING;

AGED; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; FEMALE; FOOT; GALVANIC SKIN RESPONSE; HAND; HUMANS; IONTOPHORESIS; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SWEAT GLAND DISEASES; SWEAT GLANDS;

EID: 78650020058     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabet.2010.05.004     Document Type: Article

References (24)

1. Sicree RA, Shaw JE, Zimmet PZ. Diabetes impaired glucose tolerance - prevalence and projections. In: Gan D, editor. Diabetes Atlas, 3rd ed. International Diabetes Federation, Brussels; 2006. p. 15-103.
2. Shaw J.E., Sicree R.A., Zimmet P.Z. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010, 87:4-14.
3. Vinik A.I., Mason R.E., Mitchell B.D., Freeman R. Diabetic Autonomic neuropathy. Diabetes Care 2003, 26:1553-1579.
4. Krishnan S.T., Rayman G. The LDIflare: a novel test of C-fiber function demonstrates early neuropathy in type 2 diabetes. Diabetes Care 2004, 27:2930-2935.
5. Young M.J., Boulton A.J., MacLeod A.F., Williams D.R., Sonksen P.H. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993, 36:150-154.
6. Boulton A.J., Vileikyte L., Ragnarson-Tenvall G., Apelqvist J. The global burden of diabetic foot disease. Lancet 2005, 366:1719-1724.
7. Low L.A., Sandroni P., Fealey R.D., Low P.A. Detection of small-fiber neuropathy by sudomotor testing. Muscle Nerve 2006, 34:57-61.
8. Jaradeh S.S., Prieto T.E. Evaluation of the autonomic nervous system. Phys Med Rehabil Clin N Am 2003, 14:287-305.
9. Chizmadzhev Y.A., Indenborn A.V., Kuzmin P.I., Galichenko S.V., Weaver J.C., Potts R.O. Electrical properties of skin at moderate voltages: contribution of appendageal macropores. Biophys J 1998, 74:843-856.
10. Brunswick P., Mayaudon H., Albin V., Lair V., Ringuede A., Cassir M. Use of Ni electrodes chronoamperometry for improved diagnostics of diabetes and cardiac diseases. Conf Proc IEEE Eng Med Biol Soc 2007, 4544-4547.
11. Bland J.M., Altman D.G. Measuring agreement in method comparison studies. Stat Methods Med Res 1999, 8:135-160.
12. Metz C.E. Basic principles of ROC analysis. Semin Nucl Med 1978, 8:283-298.
13. The R Project for Statistical Computing. http://www.r-project.org/.
14. Sing T., Sander O., Beerenwinkel N., Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005, 21:3940-3941.
15. Hoeldtke R.D., Bryner K.D., Horvath G.G., Phares R.W., Broy L.F., Hobbs G.R. Redistribution of sudomotor responses is an early sign of sympathetic dysfunction in Type 1 diabetes. Diabetes 2001, 50:436-443.
16. Quinton P.M. Cystic fibrosis: a disease in electrolyte transport. FASEB J 1990, 4:2709-2717.
17. Quinton P.M. Cystic fibrosis: lessons from the sweat gland. Physiology (Bethesda) 2007, 22:212-225.
18. Gonska T., Ip W., Turner D., et al. Sweat gland bioelectrics differ in cystic fibrosis: a new concept for potential diagnosis and assessment of CFTR function in cystic fibrosis. Thorax 2009, 64:932-938.
19. Papanas N., Giassakis G., Papatheodorou K., Papazoglou D., Monastiriotis C., Christakidis D., et al. Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study. J Diabetes Complications 2007, 21:353-358.
20. Gin H., Perlemoine C., Rigalleau V. How to better systematize the diagnosis of neuropathy?. Diabetes Metab 2006, 32:367-372.
21. Sumner C.J., Sheth S., Comblath D.R., Polydefkis M. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003, 60:108-111.
22. Putz Z., Tabák A.G., Tóth N., et al. Noninvasive evaluation of neural impairment in subjects with impaired glucose tolerance. Diabetes Care 2009, 32:181-183.
23. Grandinetti A., Chow D., Sletten M., Oyama J., Theriault A., Schatz I., Low P. Impaired glucose tolerance is associated with postganglionic sudomotor impairment. Clin. Auton. Res 2007, 17:231-233.
24. Mishra A., Greaves R., Smith K., Carlin J.B., Wootton A., Stirling R., et al. Diagnosis of cystic fibrosis by sweat testing: age-specific reference intervals. J Pediatr 2008, 153:758-763.